Skip to main content
. 2020 Aug 29;24(19):11500–11511. doi: 10.1111/jcmm.15764

TABLE 1.

Demographic and clinicopathological characteristics of the participants of this study

Parameter Healthy control (N = 62) HF + pEF (N = 62) HF + rEF (N = 62) P value
Age (y) 70.8 ± 6.5 73.5 ± 6.6 68.7 ± 7.4 .561
Sex, Male (%) 36 (58.1) 36 (58.1) 34 (54.8) .817
SBP (mm Hg) 137.3 ± 5.7 124.4 ± 6.2 116.8 ± 5.6 <.01
DBP (mm Hg) 84.2 ± 5.2 74.2 ± 6.5 68.5 ± 5.9 <.01
Heart rate, b.p.m. 73.2 ± 6.4 78.2 ± 6.1 73.2 ± 5.4 .569
BMI (kg/m2) 28.6 ± 2.6 32.8 ± 2.1 28.9 ± 3.1 <.01
Hypertension, % 48 (77.4) 51 (82.3) 23 (37.4) .450
Diabetes mellitus, % 13 (21.0) 18 (29.0) 8 (12.9 <.01
Dyslipidaemia, % 37 (59.7) 35 (56.5) 40 (64.5) .224
Ischaemic heart disease, % 16 (25.8) 30 (48.4) 41 (66.1) <.01
Atrial fibrillation, % 7 (11.3) 48 (77.4) 35 (56.5) <.01
BNP, pg/mL 32.5 ± 4.5 235.0 ± 44.1 126.7 ± 33.7 <.01
Echocardiography
Ejection fraction 66.0 ± 10.2 64.8 ± 13.6 37.6 ± 7.9 <.01
Interventricular septum, mm 11.8 ± 1.6 12.6 ± 1.1 11.0 ± 0.7 .070
Posterior wall, mm 9.7 ± 3.5 10.9 ± 3.3 9.8 ± 2.2 <.01
LVMI, g/m2 96.2 ± 16.7 118.1 ± 13.0 127.4 ± 17.7 <.01
LAVI, mL/m2 30.8 ± 9.4 51.1 ± 3.5 46.0 ± 7.1 <.01
Deceleration time, ms 197.8 ± 36.6 218.0 ± 27.7 235.7 ± 40.1 <.01
e'(lat), cm/s 8.5 ± 2.4 9.6 ± 1.8 8.1 ± 2.0 <.05
Peak E, cm/s 74.8 ± 28.8 96.2 ± 22.3 66.5 ± 29.3 <.01
E/e' ratio 9.5 ± 1.6 11.8 ± 2.9 9.6 ± 1.9 <.01

Abbreviations: BMI, body mass index; BNP, brain natriuretic peptide; DBP, diastolic blood pressure; E/e’ ratio, transmitral early peak velocity to E' ratio; LAVI, left atrial volume index; LVMI, left ventricular mass index; SBP, systolic blood pressure.